The TCL1A oncoprotein interacts directly with the NF-κB inhibitor IκB

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Ropars, Virginie ^a,b,c   Despouy, Gilles ^d,e,g   Stern, Marc Henri ^d,e   Benichou, Serge ^b,f   Roumestand, Christian ^a,b,c   Arold, Stefan T ^a,b,c  

^a CENTRE DE BIOCHIMIE STRUCTURALE   (France)

^b INSERM   (France)

^c UNIV MONTPELLIER   (France)

^d INSTITUT CURIE   (France)

^e INSTITUT CURIE   (France)

^f INSTITUT COCHIN   (France)

^g UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; I KAPPA B; ONCOPROTEIN; PROTEIN KINASE B; RECOMBINANT PROTEIN; T CELL LEUKEMIA LYMPHOMA 1A ONCOPROTEIN; UNCLASSIFIED DRUG; I KAPPA B KINASE; TCL1A PROTEIN, HUMAN;

ARTICLE; BINDING ASSAY; BINDING SITE; CELL STRAIN HEK293; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTAL STRUCTURE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STRUCTURE ANALYSIS; TRANSIENT EXPRESSION; TWO HYBRID SYSTEM; X RAY CRYSTALLOGRAPHY; METABOLISM; RADIATION SCATTERING;

HUMANS; I-KAPPA B KINASE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; SCATTERING, RADIATION;

EID: 68749103462     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006567     Document Type: Article

References (28)

1. Teitell MA (2005) The TCL1 family of oncoproteins: co-activators of transformation. Nat Rev Cancer 5: 640-648.
2. Noguchi M, Ropars V, Roumestand C, Suizu F (2007) Proto-oncogene TCL1: more than just a coactivator for Akt. Faseb J 21: 2273-2284.
3. Laine J, Kunstle G, Obata T, Sha M, Noguchi M (2000) The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell 6: 395-407.
4. Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, et al. (2000) Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci U S A 97: 3028-3033.
5. Auguin D, Barthe P, Royer C, Stern MH, Noguchi M, et al. (2004) Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins. J Biol Chem 279: 35890-35902.
6. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274.
7. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, et al. (1999) NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
8. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
9. Pekarsky Y, Zanesi N, Aqeilan RI, Croce CM (2007) Animal models for chronic lymphocytic leukemia. J Cell Biochem 100: 1109-1118.
10. Pekarsky Y, Palamarchuk A, Maximov V, Efanov A, Nazaryan N, et al. (2008) Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci U S A 105: 19643-19648.
11. Huxford T, Huang DB, Malek S, Ghosh G (1998) The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 95: 759-770.
12. Jacobs MD, Harrison SC (1998) Structure of an IkappaBalpha/NF-kappaB complex. Cell 95: 749-758.
13. Koch MH, Vachette P, Svergun DI (2003) Small-angle scattering: a view on the properties, structures and structural changes of biological macromolecules in solution. Q Rev Biophys 36: 147-227.
14. TCL1, an oncogene product involved in T-cell prolymphocytic leukemia, reveals a novel beta-barrel topology. Structure 6: 147-155.
15. Svergun DI, Petoukhov MV, Koch MH (2001) Determination of domain structure of proteins from X-ray solution scattering. Biophys J 80: 2946-2953.
16. Svergun DI, Barberato C, Koch MHJ (1995) CRYSOL - a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates. J Appl Cryst 28: 768-773.
17. Volkov VV, Svergun DI (2003) Uniqueness of ab initio shape determination in small-angle scattering. J Appl Cryst. pp 860-864.
18. Despouy G, Joiner M, Le Toriellec E, Weil R, Stern MH (2007) The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways. Blood 110: 4406-4416.
19. Bergqvist S, Croy CH, Kjaergaard M, Huxford T, Ghosh G, et al. (2006) Thermodynamics reveal that helix four in the NLS of NF-kappaB p65 anchors IkappaBalpha, forming a very stable complex. J Mol Biol 360: 421-434.
20. Tergaonkar V, Correa RG, Ikawa M, Verma IM (2005) Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat Cell Biol 7: 921-923.
21. Bouhamdan M, Benichou S, Rey F, Navarro JM, Agostini I, et al. (1996) Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J Virol 70: 697-704.
22. Despouy G, Bastie JN, Deshaies S, Balitrand N, Mazharian A, et al. (2003) Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II. J Biol Chem 278: 6355-6362.
23. Huxford T, Malek S, Ghosh G (2000) Preparation and crystallization of dynamic NF-kappa B.Ikappa B complexes. J Biol Chem 275: 32800-32806.
24. Kiernan R, Bres V, Ng RW, Coudart MP, El Messaoudi S, et al. (2003) Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J Biol Chem 278: 2758-2766.
25. Auguin D, Barthe P, Auge-Senegas MT, Stern MH, Noguchi M, et al. (2004) Solution structure and backbone dynamics of the pleckstrin homology domain of the human protein kinase B (PKB/Akt). Interaction with inositol phosphates. J Biomol NMR 28: 137-155.
26. Konarev PV, Vladimir VV, Sokolova AV, Koch MJ, Svergun DI (2003) PRIMUS: a Window PC-based system for small-angle scattering data. J Appl Cryst 36: 1277-1282.
27. Petoukhov MV, Svergun DI (2005) Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys J 89: 1237-1250.
28. Svergun DI (1992) Determination of the Regularization Parameter in Indirect-Transform Methods Using Perceptual Criteria. J Appl Cryst 25: 495-503.